Oxford BioMedica Interim Management Statement May 2011
Oxford, UK – 18 May 2011: Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE: OXB), a leading gene therapy company, today publishes its interim management statement for the period from…